Lork Group Awarded DCI ISO 13485 Certification

2026-05-11

Overview

Recently, Lork Group successfully passed the audit conducted by DCI Certification Ltd., thereby obtaining ISO 13485:2016 certification for its Quality Management System for Medical Devices (Certificate No.: 206487). The scope of this certification covers "Sales Management of High-Quality Specialty Steels and High-Performance Alloys for the Medical Device Sector — Distribution Services Category (Code: Components or Services — Distribution Services)."

Fifteen Years of Accumulated Expertise

Strategic Pre-emptive Positioning in Medical Specialty Steels

Achieving ISO 13485 certification was not accomplished overnight. Tracing the company's trajectory, Lork Group officially launched its medical specialty steel product line in 2018, encompassing specialized steels dedicated to biomedical applications, medical implants, and medical devices. Subsequently, between 2021 and 2023, the company completed the optimization and integration of its supply chain matrix—selecting over 300 key manufacturing facilities and 40 core strategic partners from a pool of more than 600 supply channels—thereby establishing a comprehensive, full-lifecycle quality control system spanning smelting, forging, heat treatment, and precision machining.

To date, Lork Group has secured numerous authoritative international certifications, including ISO 9001, AS9100 (Aerospace), ISO 28000 (Supply Chain Security), ISO 45001 (Occupational Health and Safety), ISO 24001 (Environmental Management), and CE product safety certification. The recent addition of ISO 13485 serves as the "final puzzle piece," completing the company's quality management system within the medical device distribution sector.

Significance of Certification

ISO 13485 is an internationally recognized standard for quality management systems within the medical device industry; its full title is *Medical devices — Quality management systems — Requirements for regulatory purposes*. Unlike the general-purpose ISO 9001 standard, ISO 13485 emphasizes operation within a regulatory framework. It covers the entire product lifecycle—from design and development, production, and storage, through to distribution and servicing—while imposing more stringent requirements regarding documentation management and traceability.

For Lork Group, the core value of this certification lies not merely in demonstrating "manufacturing capability," but rather in validating the company's systematic control capabilities regarding the distribution of specialty steels within the medical device sector. The specific certification code explicitly designates "Distribution services"—signifying that Lork Group has established standardized processes that fully comply with international regulatory requirements for medical devices across the following key areas:

Supplier Qualification and Auditing: Conducting rigorous screening of upstream smelting and processing facilities to ensure that raw materials are accompanied by complete documentation verifying their regulatory compliance;
Warehousing and Logistics Control: Implementing mechanisms for temperature and humidity control, packaging integrity verification, and batch traceability, specifically tailored to meet the unique requirements of medical-grade materials;
Documented Traceability System: Maintaining fully traceable archives for every material batch, encompassing quality certificates, furnace numbers, processing records, and distribution flow information;
Customer Complaint and Recall Response: Establishing mechanisms for market surveillance and rapid response to product-related issues, thereby meeting the requirements for the distribution phase stipulated by international regulations—such as the EU Medical Device Regulation (MDR).

DCI Certification Ltd.: An Internationally Accredited Professional Certification Body

The issuing body for this certification, DCI Certification Ltd., is an international certification organization holding multi-system accreditation credentials. Its services encompass management system certifications such as ISO 13485, ISO 9001, and AS9100, and it maintains a team of highly experienced auditors within the country. Its audit process consists of two stages—a Phase 1 document review and a Phase 2 on-site audit—with a primary focus on verifying the organization's actual operational capabilities across four key dimensions: regulatory compliance, supplier control, product traceability, and continuous improvement.

Lork Group officially received its certification on April 27, 2026. The certificate is valid for a period of three years, during which time the organization is required to undergo annual surveillance audits to maintain the validity of its certification.

The Foundation of Global Customer Trust

Currently, Lork Group serves over 2,000 strategic clients across more than 50 countries, spanning critical sectors such as aero-engines, biomedical implants, semiconductor manufacturing, and energy equipment. In the field of specialized medical steels, the company supplies a diverse range of materials—including 316LVM medical-grade stainless steel, cobalt-based alloys, titanium alloys, and nickel-titanium shape memory alloys—to numerous international medical device manufacturers. These materials are utilized in end-use applications such as orthopedic implants, surgical instruments, and dental consumables.

The official issuance of the DCI ISO 13485 certification will secure for the company enhanced regulatory recognition from international clients within the medical device supply chain management sector. For regulatory frameworks such as the EU MDR, US FDA, and Canada MDSAP—all of which mandate that suppliers possess robust, systemic quality management capabilities—this certification serves as an indispensable "passport to market entry."

About Lork Group

Lork Group is a specialized steel supply chain management group headquartered in Zhengzhou, China. The company focuses on providing full-lifecycle supply chain services for high-end metal materials—including high-temperature alloys, nickel-based alloys, medical-grade specialty steels, and duplex stainless steels. With a network of over 400 rigorously vetted manufacturing facilities, the Group has served more than 2,000 manufacturing enterprises across over 50 countries worldwide, spanning strategic sectors such as aerospace, biomedical technology, energy equipment, and semiconductor chips. For more information, please visit: //www.lorksteels.com/en/about-us.html

Media Contact

Lork Group | Brand & Marketing Department
Email: daisy@lorkgroup.com
Phone: +86 175 1308 1871

NIMONIC Alloys-Extreme High-Temperature and Corrosive Applications

Lork Group Response to Alloy 49 Wire Surface Defect Complaint